{"title": "Farmacoepidemiolog\u00eda de los f\u00e1rmacos antagonistas de los receptores de angiotensina (ARA) II en el tratamiento de la hipertensi\u00f3n arterial esencial. M\u00e9xico", "author": "Adela Alba-Leonel; Guillermo Fajardo-Ortiz; Joaqu\u00edn Papaqui-Hern\u00e1ndez", "url": null, "hostname": null, "description": "Epidemiology of hypertension: Epidemiology of hypertension globally, it is reported that the prevalence of hypertension in adult population is between 20-27%. Pharmacotherapy: ARA II exert their action by blocking AT1 receptors Angiotensin II in a specific and highly selective and act by inhibiting the adverse effects angiotesin II classic. Thus, antagonize the action of angiotensin II produced by any means and do not act on enzymatic degradation of kinins, so do not condition an increase in blood levels. In addition to the ATI receptor blockade ARA II allow the circulating Angiotensin II may be linked to the AT2 receptor, which can add an additional potentially beneficial. Studies of morbidity and mortality in hypertension with ARA II: The efficacy of ARA II for lowering blood pressure is well established for several years, both in mild hypertension and moderate or severe and multiple studies comparing these drugs have shown similar antihypertensive efficacy to that of IECA inhibitors, calcium antagonists or beta-blockers. Therefore, given similar antihypertensive efficacy and better tolerability profile the ARA II may be considered a very useful drug family in the current treatment of hypertension. Conclusions: The conclusion of the authors of several studies is that IECA inhibitors and ARA II have similar antihypertensive effectiveness and IECA inhibitors, poorer tolerability.", "sitename": "Revista de Enfermer\u00eda Neurol\u00f3gica", "date": "2014-12-31", "id": null, "license": "CC BY-NC 4.0", "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Farmacoepidemiolog\u00eda de los f\u00e1rmacos antagonistas de los receptores de angiotensina (ARA) II en el tratamiento de la hipertensi\u00f3n arterial esencial. M\u00e9xico\nDOI:\n[https://doi.org/10.51422/ren.v13i3.198](https://doi.org/10.51422/ren.v13i3.198)\nPalabras clave:Hipertensi\u00f3n arterial esencial, ARA II, eficacia de los ARA II, IECA,, farmacoepidemiolog\u00eda\nResumen\nEpidemiolog\u00eda de la hipertensi\u00f3n arterial: A nivel mundial, se reporta que la prevalencia de hipertensi\u00f3n arterial en poblaci\u00f3n adulta se encuentra entre un 20-27%. Tratamiento farmacol\u00f3gico: Los ARA II ejercen su acci\u00f3n a trav\u00e9s del bloqueo de los receptores AT1 de la angiotensina II de forma espec\u00edfica y altamente selectiva y act\u00faan inhibiendo los efectos cl\u00e1sicos desfavorables de angiotensina II. As\u00ed, los ARA II antagonizan la acci\u00f3n de la angiotensina II producida por cualquier v\u00eda enzim\u00e1tica y no act\u00faan sobre la degradaci\u00f3n de las quininas, por lo que no condicionan un aumento de sus niveles en sangre. Adem\u00e1s, al bloquear los receptores ATI los ARA II permiten que la angiotensina II circulante se pueda ligar a los receptores AT2, lo que puede a\u00f1adir un efecto adicional potencialmente muy beneficioso. Estudios de morbimortalidad en Hipertensi\u00f3n con ARA II: La eficacia de los ARA II para disminuir la tensi\u00f3n arterial est\u00e1 demostrada desde hace varios a\u00f1os, tanto en HTA leve como moderada o severa, y en m\u00faltiples estudios comparativos estos f\u00e1rmacos muestran una eficacia antihipertensiva similar a la de los IECAS, antagonistas del calcio o betabloqueantes. Por tanto, ante una eficacia antihipertensiva similar y un mejor perfil de tolerabilidad, los ARA II pueden considerarse una familia farmacol\u00f3gica de gran utilidad en el tratamiento actual de la HTA. Conclusiones: La conclusi\u00f3n de los autores de diversos estudios es que los IECA y los ARA-II tienen una efectividad antihipertensiva similar y los IECA, una peor tolerabilidad.", "language": null, "image": null, "pagetype": null, "links": ["#pkp_content_main", "#siteNav", "#pkp_content_footer", "\t\t\t\t\t\thttps://revenferneurolenlinea.org.mx/index.php/enfermeria/index\n\t\t\t\t\t", null, "https://revenferneurolenlinea.org.mx/index.php/enfermeria", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/issue/archive", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/about", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/sobre-revista", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/objetivo-y-alcance", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/cuerpo-editorial", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/directorio", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/comite-cientifico", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/gestion-tecnica", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/frecuencia-de-publicacion", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/declaracion-de-privacidad", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/financiamiento", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/contacto", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/index/#", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/normas-para-autores", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/secciones", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/gestion-editorial", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/formatos", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/about/submissions", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/politicasenfermeria", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/revision", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/politicasseccion", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/politicas_acceso_abierto", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/codigo-de-etica", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/politicas_autoria", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/derechos-autor", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/politicas-de-similitud", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/politicas-de-retraccion", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/gateway/lockss", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/funciones", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/deposito-datos-investigacion", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/lenguaje-inclusivo", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/interoperabilidad", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/index/#", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/tutoriales", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/guias-de-evaluacion", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/estadisticas", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/search", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/user/register", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/login", null, "https://revenferneurolenlinea.org.mx/index.php/enfermeria/index", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/issue/archive", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/issue/view/23", "https://doi.org/10.51422/ren.v13i3.198", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/issue/view/23", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/article/view/198/198", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/acm-sig-proceedings?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/acs-nano?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/apa?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/associacao-brasileira-de-normas-tecnicas?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/chicago-author-date?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/harvard-cite-them-right?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/ieee?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/modern-language-association?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/turabian-fullnote-bibliography?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/get/vancouver?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/download/ris?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/citationstylelanguage/download/bibtex?submissionId=198&publicationId=110", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/issue/view/23", null, null, null, null, null, null, "https://portal.issn.org/resource/ISSN/2954-3428", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/about/submissions", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/information/readers", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/information/authors", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/information/librarians", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/user/setLocale/en_US?source=%2Findex.php%2Fenfermeria%2Farticle%2Fview%2F198", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/user/setLocale/es_ES?source=%2Findex.php%2Fenfermeria%2Farticle%2Fview%2F198", "https://twitter.com/DeNeurologica", "https://creativecommons.org/licenses/by-nc/4.0/", "https://innn.edu.mx/", "https://creativecommons.org/licenses/by-nc/4.0/", null, "https://www.gob.mx/salud/innn", "https://laboratoriosarmstrong.mx", "https://revenferneurolenlinea.org.mx/index.php/enfermeria/about/aboutThisPublishingSystem"]}